Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM N : DSM announces results of 2021 Annual General Meeting of Shareholders

05/06/2021 | 11:37am EDT

Heerlen, NL, 06 May 2021 17:30 CEST

Royal DSM today held its fully virtual Annual General Meeting of Shareholders. Shareholders approved all resolutions on the agenda.

The following resolutions were approved at the Annual General Meeting of Shareholders:

  • An amendment of the Articles of Association
  • The Remuneration Report received a positive advisory vote
  • Adoption of the Financial Statements for 2020
  • Adoption of the dividend on ordinary shares for 2020 (see also separate press release)
  • Release from liability of the members of the Managing Board in respect of their managerial activities
  • Release from liability of the members of the Supervisory Board in respect of their supervisory role
  • Reappointment of Dimitri de Vreeze as a member of the Managing Board
  • Reappointment of Frits van Paasschen and John Ramsay as members of the Supervisory Board
  • Appointment of Carla Mahieu and Corien M. Wortmann-Kool as members of the Supervisory Board
  • Reappointment of the external auditor
  • Authorization of the Managing Board to issue up to 10% ordinary shares and to exclude pre-emptive rights
  • Authorization of the Managing Board to issue an additional 10% ordinary shares in connection with a rights issue
  • Authorization of the Managing Board to have the company repurchase shares
  • Reduction of the issued capital by canceling shares

Disclaimer

Koninklijke DSM NV published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 15:36:01 UTC.


ę Publicnow 2021
All news about ROYAL DSM N.V.
06/17ROYAL DSM Ná : DSM - repurchase of shares (14-15 June 2021)
PU
06/16ROYAL DSM Ná : to Redeem $607 Million Bond Ahead of Schedule
MT
06/16ROYAL DSM Ná : DSM concludes early redemption of Ç500 million bond
PU
06/15ROYAL DSM Ná : DSM - repurchase of shares (7-11 June 2021)
PU
06/10ROYAL DSM Ná : CEOs and investors push world leaders for stronger climate action
RE
06/08ROYAL DSM Ná : DSM - repurchase of shares (31 May - 4 June 2021)
PU
06/03ROYAL DSM Ná : DSM completes sale of DSM Advanced Solar backsheets business to W..
PU
06/01ROYAL DSM Ná : DSM - repurchase of shares (24-28 May 2021)
PU
05/25ROYAL DSM Ná : DSM - repurchase of shares (17-21 May 2021)
PU
05/19ROYAL DSM Ná : DSM to Redeem $611 Million Bond Ahead of Maturity
MT
More news
Financials
Sales 2021 8 715 M 10 413 M 10 413 M
Net income 2021 910 M 1 087 M 1 087 M
Net Debt 2021 1 160 M 1 385 M 1 385 M
P/E ratio 2021 27,6x
Yield 2021 1,65%
Capitalization 26 907 M 32 097 M 32 149 M
EV / Sales 2021 3,22x
EV / Sales 2022 3,01x
Nbr of Employees 21 313
Free-Float 91,0%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 157,55 €
Average target price 153,52 €
Spread / Average Target -2,56%
EPS Revisions
Managers and Directors
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
GÚraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.11.90%32 097
BASF SE1.38%71 885
SHIN-ETSU CHEMICAL CO., LTD.1.83%68 859
DUPONT DE NEMOURS, INC.7.44%40 565
EVONIK INDUSTRIES AG5.40%15 632
ASAHI KASEI CORPORATION15.74%15 276